DE59308970D1 - Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel - Google Patents

Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel

Info

Publication number
DE59308970D1
DE59308970D1 DE59308970T DE59308970T DE59308970D1 DE 59308970 D1 DE59308970 D1 DE 59308970D1 DE 59308970 T DE59308970 T DE 59308970T DE 59308970 T DE59308970 T DE 59308970T DE 59308970 D1 DE59308970 D1 DE 59308970D1
Authority
DE
Germany
Prior art keywords
compounds
medicines
oxazolidine compounds
denote
adrenoreceptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59308970T
Other languages
German (de)
English (en)
Inventor
Alfred Dr Sallmann
Hans-Peter Dr Gschwind
Eric Dr Francotte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of DE59308970D1 publication Critical patent/DE59308970D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE59308970T 1992-09-02 1993-08-24 Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel Expired - Lifetime DE59308970D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH274292 1992-09-02

Publications (1)

Publication Number Publication Date
DE59308970D1 true DE59308970D1 (de) 1998-10-15

Family

ID=4240593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59308970T Expired - Lifetime DE59308970D1 (de) 1992-09-02 1993-08-24 Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel

Country Status (14)

Country Link
US (1) US5369117A (enExample)
EP (1) EP0586344B1 (enExample)
JP (1) JP3070812B2 (enExample)
KR (1) KR100306652B1 (enExample)
AT (1) ATE170848T1 (enExample)
AU (1) AU672984B2 (enExample)
CA (1) CA2105215C (enExample)
DE (1) DE59308970D1 (enExample)
DK (1) DK0586344T3 (enExample)
ES (1) ES2121071T3 (enExample)
IL (1) IL106862A (enExample)
NZ (1) NZ248550A (enExample)
TW (1) TW223065B (enExample)
ZA (1) ZA936393B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
CA2163399A1 (en) * 1994-11-24 1996-05-25 Katsuhiro Kawano Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2305092A1 (de) * 1972-02-05 1973-08-16 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzylalkoholderivate
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
US4219655A (en) * 1979-07-16 1980-08-26 Stauffer Chemical Company Process for the production of N-acyl substituted oxazolidines
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4705798A (en) * 1985-09-27 1987-11-10 University Of Iowa Research Foundation Phenylephrine prodrug useful as mydriatic agent
US5066793A (en) * 1987-10-26 1991-11-19 Ciba-Geigy Corporation Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids, process for their preparation, and the use thereof

Also Published As

Publication number Publication date
DK0586344T3 (da) 1999-06-07
EP0586344A1 (de) 1994-03-09
TW223065B (enExample) 1994-05-01
JPH06157487A (ja) 1994-06-03
KR940007010A (ko) 1994-04-26
JP3070812B2 (ja) 2000-07-31
IL106862A (en) 1997-07-13
AU672984B2 (en) 1996-10-24
ES2121071T3 (es) 1998-11-16
AU4499393A (en) 1994-03-10
CA2105215A1 (en) 1994-03-03
EP0586344B1 (de) 1998-09-09
CA2105215C (en) 2004-06-29
ZA936393B (en) 1994-03-25
IL106862A0 (en) 1993-12-28
ATE170848T1 (de) 1998-09-15
KR100306652B1 (ko) 2001-12-28
NZ248550A (en) 1995-09-26
US5369117A (en) 1994-11-29

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
CA2203274A1 (en) Apolipoprotein-b synthesis inhibitors
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
MY132062A (en) Apolipoprotein-b synthesis inhibitors
DK492288D0 (da) Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne
EP0712398A1 (en) BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO873722D0 (no) Nye derivater av 4,5-dihydro-oksazoler, samt fremgangsmaate for deres fremstilling.
ATE170848T1 (de) Oxazolidin verbindungen und ihre verwendung als arzneimittel
DK0457883T3 (da) Nye bicycliske aminosubstituerede forbindelser
NO923004D0 (no) 6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
MD1687F2 (en) Arylthiocompounds, pharmaceutical composition, methods of bacterial and viral infections treatment
DE3577558D1 (de) 4-hydroxy-3-chinolincarbonsaeurederivate, 2-substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte.
ES8202018A1 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
DK0714395T3 (da) Substituerede dihydropyranopyridiner med vasokonstriktoraktivitet
RU2220954C2 (ru) ЗАМЕЩЕННЫЕ β-АЛАНИНЫ
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
ATE74593T1 (de) 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz (e> indole, ihre herstellung und berwendung als arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition